HANCOCK WHITNEY CORP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$325,523
+18.4%
11,948
-3.5%
0.01%
+18.2%
Q2 2023$275,000
-27.2%
12,380
-29.1%
0.01%
-26.7%
Q1 2023$378,000
-7.1%
17,472
-12.8%
0.02%
-6.2%
Q4 2022$407,000
-21.1%
20,036
-0.4%
0.02%
-27.3%
Q3 2022$516,000
+5.5%
20,111
-2.3%
0.02%
+10.0%
Q2 2022$489,000
+1.7%
20,578
-3.7%
0.02%
+25.0%
Q1 2022$481,000
-5.7%
21,367
-17.0%
0.02%0.0%
Q4 2021$510,0000.0%25,733
-0.8%
0.02%
-11.1%
Q3 2021$510,000
-11.0%
25,936
-0.4%
0.02%0.0%
Q2 2021$573,000
-28.6%
26,029
-23.0%
0.02%
-33.3%
Q1 2021$803,000
-10.5%
33,784
-1.4%
0.03%
-10.0%
Q4 2020$897,000
+49.7%
34,268
-0.6%
0.03%
+36.4%
Q3 2020$599,000
+2.7%
34,465
-0.5%
0.02%0.0%
Q2 2020$583,000
+26.2%
34,636
-10.9%
0.02%
+22.2%
Q1 2020$462,000
+37.5%
38,877
+40.0%
0.02%
+63.6%
Q4 2019$336,000
-44.1%
27,760
-34.7%
0.01%
-45.0%
Q3 2019$601,000
+11.3%
42,520
-12.2%
0.02%
+17.6%
Q2 2019$540,00048,4220.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders